Key Takeaways
- Nebius Group (NBIS) shares plummeted 17% on Wednesday, hitting a low of $228.17 with trading volume jumping 85% beyond typical levels
- A Bloomberg report revealing Meta’s plans to launch a cloud infrastructure business sparked concerns about direct competition with neocloud platforms like Nebius
- The company recently delivered impressive results with $399 million in quarterly revenue — a 684% year-over-year surge — while exceeding EPS forecasts by $0.54
- Analysts maintain a “Moderate Buy” rating with 9 Buy recommendations and 6 Hold ratings; Bank of America projects a $280 target price
- Company executives have divested more than $124 million in shares over the last three months, including sales by the CTO and CRO
Meta Cloud Ambitions Trigger Sharp Decline in Nebius Group (NBIS) Stock
Shares of Nebius Group (NBIS) experienced a dramatic 17% decline on Wednesday, touching an intraday low of $228.17 before settling near $229.18. This represented a significant drop from the previous session’s close of $276.17. Trading activity surged dramatically, with volume exceeding 30 million shares — approximately 85% higher than typical daily averages.
The catalyst behind this sharp downturn was a Bloomberg article reporting that Meta Platforms intends to commercialize AI computing infrastructure and models — including direct access to GPU resources. This business model directly challenges the core offerings of neocloud specialists like Nebius and CoreWeave.
CoreWeave similarly experienced a decline exceeding 6% following the same disclosure.
The market’s reaction stems from more than just the threat of additional competition. Meta currently ranks among the world’s largest consumers of GPU computing resources. A strategic pivot toward selling capacity rather than exclusively utilizing it internally could fundamentally reshape supply dynamics across the entire neocloud sector.
Nebius and comparable players in the AI infrastructure space have benefited tremendously from surging demand for cloud-based AI services. Wednesday’s market response demonstrated how rapidly investor confidence can erode when competitive threats emerge.
Robust Growth Metrics Clash With Valuation Concerns
Notwithstanding Wednesday’s selloff, Nebius continues to demonstrate exceptional business momentum. The company posted $399 million in quarterly revenue — representing a remarkable 684% increase compared to the same period last year. Nebius also surpassed earnings projections by $0.54 per share, recording a loss of $0.23 versus the consensus estimate calling for a $0.77 loss.
Management has highlighted accelerating customer acquisition and sustained robust demand for AI computing infrastructure. However, several market observers had previously cautioned that valuation levels appeared extended following the stock’s substantial appreciation ahead of the earnings announcement.
NBIS currently trades with a 50-day moving average of $215.92 and a 200-day moving average of $142.48. Even following Wednesday’s retreat, the stock remains positioned considerably above both technical benchmarks.
The equity carries a price-to-earnings multiple of 73.93 and commands a market capitalization approaching $58 billion. Its beta coefficient of 4.03 underscores the stock’s tendency toward significant price swings — a characteristic that was vividly illustrated during Wednesday’s session.
Wall Street Perspectives and Executive Stock Sales
Analyst sentiment remains cautiously optimistic, with nine analysts recommending Buy ratings and six maintaining Hold positions, resulting in a “Moderate Buy” consensus. The average price objective stands at $203.25.
Bank of America maintains a $280 price target alongside a Buy recommendation, established in early June. BNP Paribas Exane initiated research coverage in June with a Neutral stance and $255 target. Morgan Stanley has assigned an Equal Weight rating with a $144 price objective.
Regarding insider transactions, recent activity paints a more cautious picture. The company’s CTO liquidated approximately $3.7 million in shares on June 4th, representing a 5.1% reduction in holdings. The CRO disposed of roughly $3 million worth of stock on June 2nd, decreasing his position by 28.6%.
Collectively, company insiders have sold in excess of $124 million worth of shares during the past three months.
Despite this insider selling activity, major institutional investors have been expanding their positions. Orbis Allan Gray, Fred Alger Management, and Morgan Stanley have all increased their NBIS holdings in recent reporting periods.
The analyst community forecasts Nebius will report a full-year EPS of -$1.91.





